Automated bone scan index as a quantitative imaging biomarker indicative of efficacy to enzalutamide in patients with metastatic castrate resistant prostate cancer (mCRPC) Meeting Abstract

  

Authors:	Anand, A.; Morris, M. J.; Larson, S. M.; Ohlsson, M.; Joseffson, A.; Helgstrand, J. T.; Edenbrandt, L.; Oturai, P. S.; Roeder, M. A.; Bjartell, A.
Abstract Title:	Automated bone scan index as a quantitative imaging biomarker indicative of efficacy to enzalutamide in patients with metastatic castrate resistant prostate cancer (mCRPC)
Meeting Title:	2016 Genitourinary Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	34
Issue:	2 Suppl.
Meeting Dates:	2016 Jan 7-9
Meeting Location:	San Francisco, CA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2016-01-10
Language:	English
ACCESSION:	WOS:000378109100226
PROVIDER:	wos
DOI:	10.1200/JCO.2016.34.2_suppl.226
Notes:	Meeting Abstract: 226 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/95741